Our website use cookies to improve and personalize your experience and to display advertisements (if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, and Youtube. By using the website, you consent to the use of cookies.

SA to resume J&J vaccination study

SA to resume J&J vaccination study

SOUTH African researchers hope to next week resume a study using Johnson & Johnson's COVID-19 vaccine to immunise healthcare workers, one of the scientists leading the programme said yesterday. South Africa suspended the study last week after U.S. federal health agencies recommended pausing the use of J&J's vaccine because of rare cases of blood clots. "We do hope to start again next week," South African Medical Research Council President Glenda Gray, co-principal investigator of the Sisonke study, said during a webinar on Wednesday. So far around 290,000 health workers have been given J&J's vaccine in the study, which is further…
Read More
SA plans to vaccinate 200,000 people daily

SA plans to vaccinate 200,000 people daily

SOUTH Africa plans to administer coronavirus vaccines to up to 200,000 people a day beginning around May, the Sunday Times newspaper has reported, citing Health Minister Zweli Mkhize. According to the report, more than 2,000 vaccination sites will be set up. The plan is based on the expected arrival of the first batch of 2.8 million Johnson & Johnson vaccine doses at the end of April, the newspaper said. The Health Ministry did not respond to telephone calls and text messages from Reuters seeking comment. South Africa has been the hardest hit nation on the continent by COVID-19. It has…
Read More